Aspira Women's Health Inc. (AWH) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET
Company Participants
Nicole Sandford - CEO
Sandy Milligan - President
Torsten Hombeck - CFO
Conference Call Participants
Ross Osborn - Cantor Fitzgerald
Maggie Boeye - William Blair
Do Kim - Water Tower Research
Operator
Good morning, ladies and gentlemen, and welcome to Aspira Women's Health, Incorporated. First Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. Following managements prepared remarks, we will open the call for your questions. As a reminder, this call is being recorded today.
Before we begin, I would like to remind everyone that forward-looking statements, as defined under the Private Securities Litigation Reform Act of 1995, will be made during this call, including statements relating to Aspira's expected future performance, future business prospects and future events or plans.
Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, actual outcomes and results are subject to risks and uncertainties and could differ materially from those anticipated due to the impact of many factors beyond Aspira Women's Health's control.
The company assumes no obligation to update or supplement any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Participants are directed to the cautionary note set forth in today's press release as well as the risk factors set forth in Aspira's most recent annual report on Form 10-K and quarterly report on Form 10-Q filed with the SEC. For a description of factors that could cause actual results to differ materially from those anticipated in the forward-looking statements.
At this time, I would like to call the call over to Nicole Sandford, Chief Executive Officer. Please go ahead.
Nicole Sandford
Thank
- Read more current AWHL analysis and news
- View all earnings call transcripts